Vagus Nerve Stimulation Device Adjusting Stimulation Based on Biological Signals and User Sensitivity
Summary
The European Patent Office published patent application EP4506030A1 for a vagus nerve stimulation device that automatically adjusts stimulation parameters based on the user's biological signals and individual sensitivity thresholds. The patent, filed by South Korea-based Neurive Co., Ltd., covers systems for personalized neurostimulation therapy across EPO-designated European member states.
What changed
The European Patent Office published patent EP4506030A1, a vagus nerve stimulation device invention that monitors biological signals to dynamically adjust stimulation intensity and duration based on the individual user's physiological condition and stimulation sensitivity. Invented by SONG Jae Jun, CHOI Hyuk, HONG Ki Hwan, and MOON Byoung Jong of Neurive Co., Ltd., the device integrates sensors to measure cardiac, respiratory, and other biomarkers to optimize therapeutic outcomes.
For medical device manufacturers and neurostimulation technology developers, this patent establishes intellectual property rights in EPO-designated states that may affect R&D strategies, product development pathways, and freedom-to-operate analyses. Competitors developing similar adaptive neuromodulation technologies should evaluate potential overlap with these claims covering integrated biological feedback systems.
Archived snapshot
Apr 19, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
VAGUS NERVE STIMULATION DEVICE THAT REFLECTS USER'S CONDITION AND STIMULATION SENSITIVITY THROUGH BIOLOGICAL SIGNAL
Publication EP4506030A1 Kind: A1 Apr 08, 2026
Applicants
Neurive Co., Ltd.
Inventors
SONG, Jae Jun, CHOI, Hyuk, HONG, Ki Hwan, MOON, Byoung Jong
IPC Classifications
A61N 1/36 20060101AFI20260303BHEP A61N 1/04 20060101ALI20260303BHEP A61B 5/374 20210101ALI20260303BHEP A61B 5/00 20060101ALI20260303BHEP G16H 20/30 20180101ALI20260303BHEP A61B 5/346 20210101ALI20260303BHEP A61B 5/024 20060101ALI20260303BHEP A61B 5/0531 20210101ALI20260303BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Health Informatics (G16H)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Health Informatics (G16H) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.